The Role of Hematological Inflammatory Biomarkers in the Diagnosis of Lung Cancer and in Predicting TNM Stage.

ABSTRACT

OBJECTIVE: The aim of study is to investigate whether hematological inflammatory biomarkers could be useful to detect patients with lung cancer. METHODS: The contribution of hematological biomarkers to the diagnosis of lung cancer and prediction of TNM was examined. RESULTS: NLR, PLR, MPV values were found to be higher in patients with lung cancer (all p < .001). NLR and PLR were found to be high, MPV was found to be lower in disease of advanced stage (p < .001). CONCLUSIONS: This study found that NLR, PLR and MPV values were significantly higher in patients with lung cancer.